| # | Drug | Count |
|---|---|---|
| 0 | ASPIRIN | 123 |
| 1 | ASPIRIN 325 MG | 115 |
| 2 | ASPIRIN 81 MG | 115 |
| 3 | ASPIRIN TABLET 325MG | 115 |
| 4 | CLOZAPINE | 87 |
| 5 | ONASEMNOGENE ABEPARVOVEC-XIOI | 85 |
| 6 | RAMIPRIL | 66 |
| 7 | OMEPRAZOLE MAGNESIUM | 58 |
| 8 | LISINOPRIL | 57 |
| 9 | AMLODIPINE | 56 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ONASEMNOGENE ABEPARVOVEC-XIOI | 85 | 0.0633 |
| 1 | ACETAMINOPHEN, CAFFEINE, DIHYDROCODEINE BITARTRATE | 1 | 0.0278 |
| 2 | CHLOROPROCAINE HYDROCHLORIDE | 1 | 0.0233 |
| 3 | DEXTROSE AND SODIUM CHLORIDE | 2 | 0.0213 |
| 4 | CHLORINE | 1 | 0.0204 |
| 5 | TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE | 1 | 0.0192 |
| 6 | WHITE PETROLEUM | 1 | 0.0167 |
| 7 | SANITIZING WIPES | 5 | 0.0114 |
| 8 | ETHYL ALCOHOL | 5 | 0.0102 |
| 9 | PRILOCAINE HYDROCHLORIDE | 1 | 0.0091 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 187 |
| 1 | Corticosteroid [EPC] | 146 |
| 2 | Platelet Aggregation Inhibitor [EPC] | 141 |
| 3 | Atypical Antipsychotic [EPC] | 130 |
| 4 | Benzodiazepine [EPC] | 102 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 98 |
| 6 | Proton Pump Inhibitor [EPC] | 81 |
| 7 | Angiotensin Converting Enzyme Inhibitor [EPC] | 72 |
| 8 | Platinum-based Drug [EPC] | 70 |
| 9 | beta-Adrenergic Blocker [EPC] | 69 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Histone Deacetylase Inhibitor [EPC] | 7 | 0.0027 |
| 1 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0019 |
| 2 | Lipid Emulsion [EPC] | 3 | 0.0018 |
| 3 | Antisense Oligonucleotide [EPC] | 9 | 0.0014 |
| 4 | Benzothiazole [EPC] | 2 | 0.0013 |
| 5 | Carnitine Analog [EPC] | 2 | 0.0009 |
| 6 | alpha-Glucosidase Inhibitor [EPC] | 3 | 0.0008 |
| 7 | Dopamine-2 Receptor Antagonist [EPC] | 4 | 0.0008 |
| 8 | HER2/neu Receptor Antagonist [EPC] | 37 | 0.0007 |
| 9 | CTLA-4-directed Blocking Antibody [EPC] | 21 | 0.0007 |